Physician profile
Dane C Todd
NPI 1326337981
$9,057.32
in general payments reported to CMS, 2019-2025
14 companies · $1,901 in 2025
The $1,901 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,341 · 2020: $147 · 2021: $470 · 2022: $305 · 2023: $773 · 2024: $120 · 2025: $1,901.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,532 · Food and Beverage: $1,262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,531.99 |
| Food and Beverage | $1,261.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,721.66 | 2019-2025 | |
| Smith+Nephew, INC. | $1,656.88 | 2019-2025 | Collagenase Santyl |
| Stryker Corporation | $1,609.62 | 2019-2025 | Salvation, Pro, Pangea |
| Conetic Solutions, INC. | $1,075.84 | 2021-2025 | |
| Rsw Medical Company, INC. | $674.81 | 2019 | |
| Depuy Synthes Sales INC. | $84.20 | 2019-2022 | |
| Linvatec Corporation | $50.50 | 2022-2024 | Biobrace 23mm |
| Pacira Therapeutics, INC. | $41.35 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $36.87 | 2025 | |
| Amgen INC. | $25.93 | 2019-2023 | Evenity, Prolia |
| Vericel Corporation | $24.85 | 2019 | |
| Boston Scientific Corporation | $21.86 | 2020 | |
| Mallinckrodt Hospital Products INC. | $17.09 | 2020 | |
| Sanofi-Aventis U.S. LLC | $15.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dane Todd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.